_________
false
אקס טי אל ביופרמסוטיקלס בע"מ
2
379
X T L BIOPHARMACEUTICALS LTD
Corporation no:
520039470
4313
Israel Securities Authority
Tel Aviv Stock Exchange
C001
(
Public
)
Reported via MAGNA:
31/03/2022
www.isa.gov.il
www.tase.co.il
Reference:
2022-02-039601
Time of broadcast:
00:23
00:23
Report of Periodic or Interim Report
Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Annual Report - Form 20F 2021
f20f2021_xtlbiopharmaEDGAR_isa.pdf
Link to filing on foreign stock exchange (optional):
_________
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
22/02/2022
Address:
HaCharoshet st
5
,
Ra'anana
43656
Israel
,
Tel:
09-9557080
,
Fax:
09-9519708
E-mail address:
ir@xtlbio.com
Company site:
www.xtlbio.com
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Name of the Signatory:
Kntor Ronen
Position of Signatory in the reporting corporation:
Attorney/Legal Counsel
Name of Employer Company:
Address:
abba hillel
12
,
ramat gan
5250606
Telephone:
03-6133371
Facsimile:
03-6133372
E-mail:
rkantor@dtkgc.com
1